ATC codes
C Cardiovascular system
C01 Cardiac therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral vasodilators
C05 Vasoprotectives
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the renin-angiotensin system
C10 Lipid modifying agents
A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V

ATC code C10 Lipid modifying agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C10 is part of the anatomical group C Cardiovascular system.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC10...^[2]

Contents 1 C10A Lipid modifying agents, plain 1.1 C10AA HMG CoA reductase inhibitors 1.2 C10AB Fibrates 1.3 C10AC Bile acid sequestrants 1.4 C10AD Nicotinic acid and derivatives 1.5 C10AX Other lipid modifying agents 2 C10B Lipid modifying agents, combinations 2.1 C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents 2.2 C10BX HMG CoA reductase inhibitors, other combinations 3 References

[edit] C10A Lipid modifying agents, plain

[edit] C10AA HMG CoA reductase inhibitors

C10AA01 Simvastatin

C10AA02 Lovastatin

C10AA03 Pravastatin

C10AA04 Fluvastatin

C10AA05 Atorvastatin

C10AA06 Cerivastatin

C10AA07 Rosuvastatin

C10AA08 Pitavastatin

[edit] C10AB Fibrates

C10AB01 Clofibrate

C10AB02 Bezafibrate

C10AB03 Aluminium clofibrate

C10AB04 Gemfibrozil

C10AB05 Fenofibrate

C10AB06 Simfibrate

C10AB07 Ronifibrate

C10AB08 Ciprofibrate

C10AB09 Etofibrate

C10AB10 Clofibride

[edit] C10AC Bile acid sequestrants

C10AC01 Colestyramine

C10AC02 Colestipol

C10AC03 Colextran

C10AC04 Colesevelam

[edit] C10AD Nicotinic acid and derivatives

C10AD01 Niceritrol

C10AD02 Nicotinic acid

C10AD03 Nicofuranose

C10AD04 Aluminium nicotinate

C10AD05 Nicotinyl alcohol (pyridylcarbinol)

C10AD06 Acipimox

C10AD52 Nicotinic acid, combinations

[edit] C10AX Other lipid modifying agents

C10AX01 Dextrothyroxine

C10AX02 Probucol

C10AX03 Tiadenol

C10AX05 Meglutol

C10AX06 Omega-3-triglycerides

C10AX07 Magnesium pyridoxal 5-phosphate glutamate

C10AX08 Policosanol

C10AX09 Ezetimibe

C10AX10 Alipogene tiparvovec

[edit] C10B Lipid modifying agents, combinations

[edit] C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents

C10BA01 Lovastatin and nicotinic acid

C10BA02 Simvastatin and ezetimibe

C10BA03 Pravastatin and fenofibrate

[edit] C10BX HMG CoA reductase inhibitors, other combinations

C10BX01 Simvastatin and acetylsalicylic acid

C10BX02 Pravastatin and acetylsalicylic acid

C10BX03 Atorvastatin and amlodipine

[edit] References

v • d • e Lipid modifying agents (C10) GI tract Cholesterol absorption inhibitor, NPC1L1 Ezetimibe • SCH-48461 Bile acid sequestrants/resins (LDL) Cholestyramine • Colestipol • Colestilan • Colextran • Colesevelam Liver Statins (HMG-CoA reductase, LDL) Simvastatin# • Atorvastatin • Fluvastatin • Lovastatin • Mevastatin • Pitavastatin • Pravastatin • Rosuvastatin • Cerivastatin‡ Niacin and derivatives (HDL and LDL) Niceritrol • Niacin • Nicofuranose • Aluminium nicotinate • Nicotinyl alcohol • Acipimox Blood vessels Fibrates (PPAR) Clofibrate‡ • Bezafibrate • Aluminium clofibrate • Gemfibrozil • Fenofibrate • Simfibrate • Ronifibrate • Ciprofibrate • Etofibrate • Clofibride • Clinofibrate CETP inhibitors (HDL) Anacetrapib† • Torcetrapib§ • JTT-705 Combinations Niacin/lovastatin • Niacin/simvastatin • Ezetimibe/simvastatin • Niacin/laropiprant Other Dextrothyroxine • Probucol • Tiadenol • Benfluorex • Meglutol • Omega-3-triglycerides • Magnesium pyridoxal 5-phosphate glutamate • Policosanol • Lapaquistat§ • Alipogene tiparvovec #WHO-EM. ‡Withdrawn from market. CLINICAL TRIALS: †Phase III. §Never to phase III